Application 213917
- Type
- ANDA
- Sponsor
- GLAND PHARMA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MAGNESIUM SULFATE IN PLASTIC CONTAINER | MAGNESIUM SULFATE | INJECTABLE;INJECTION | 2GM/50ML (40MG/ML) | No | No |
| 002 | MAGNESIUM SULFATE IN PLASTIC CONTAINER | MAGNESIUM SULFATE | INJECTABLE;INJECTION | 4GM/100ML (40MG/ML) | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 25021-612 | Magnesium Sulfate | Magnesium Sulfate Heptahydrate | Sagent Pharmaceuticals | ANDA | Current |
| 47335-992 | MAGNESIUM SULFATE | magnesium sulfate heptahydrate | Sun Pharmaceutical Industries, Inc. | ANDA | Current |
| 68083-396 | MAGNESIUM SULFATE | MAGNESIUM SULFATE HEPTAHYDRATE | Gland Pharma Limited | ANDA | Current |
| 68083-397 | MAGNESIUM SULFATE | MAGNESIUM SULFATE HEPTAHYDRATE | Gland Pharma Limited | ANDA | Current |